Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 143 entries
View as:

Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT Instrument

Phase: N/A Priority: Normal
NCT ID: NCT01847014 Org: User:
Start: 09/01/13 End: 11/30/17 Due: 11/30/18

Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT00109681 Org: User:
Start: 04/30/05 End: 10/31/06 Due: 10/31/07

Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT02070991 Org: User:
Start: 07/01/14 End: 11/01/15 Due: 11/01/16

BUILD 3: Bosentan Use in Interstitial Lung Disease

Phase: N/A Priority: Normal
NCT ID: NCT00391443 Org: User:
Start: 02/28/07 End: 07/31/10 Due: 07/31/11

FUTURE 3 Study Extension

Phase: N/A Priority: Normal
NCT ID: NCT01338415 Org: User:
Start: 03/08/11 End: 05/29/20 Due: 05/29/21

Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03153137 Org: User:
Start: 08/14/17 End: 07/26/21 Due: 07/26/22

Adult Congenital Heart Disease Registry (QuERI)

Phase: N/A Priority: Normal
NCT ID: NCT01659411 Org: User:
Start: 12/01/11 End: 05/16/18 Due: 05/16/19

Bosentan in Children With Pulmonary Arterial Hypertension Extension Study

Phase: N/A Priority: Normal
NCT ID: NCT00319020 Org: User:
Start: 08/23/05 End: 10/28/11 Due: 10/28/12

Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00660179 Org: User:
Start: 05/31/08 End: 04/30/12 Due: 04/30/13

Effect of Bosentan in Patients With Metastatic Melanoma Treated With Dacarbazine (DTIC)

Phase: N/A Priority: Normal
NCT ID: NCT01009177 Org: User:
Start: 09/30/05 End: 02/29/08 Due: 02/28/09

Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00453414 Org: User:
Start: 07/31/06 End: 10/31/06 Due: 10/31/07

Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)

Phase: N/A Priority: Normal
NCT ID: NCT02907177 Org: User:
Start: 03/30/17 End: 03/26/20 Due: 03/26/21

ACT-128800 in Patients With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01208090 Org: User:
Start: 10/31/10 End: 11/30/12 Due: 11/30/13

Bosentan in Digital Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT00319696 Org: User:
Start: 07/08/04 End: 01/22/09 Due: 01/22/10

Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01470144 Org: User:
Start: 06/01/11 End: 07/01/15 Due: 07/01/16

Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443

Phase: N/A Priority: Normal
NCT ID: NCT00631475 Org: User:
Start: 04/30/08 End: 05/31/10 Due: 05/31/11

Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01474122 Org: User:
Start: 12/31/11 End: 02/28/14 Due: 02/28/15

Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea

Phase: N/A Priority: Normal
NCT ID: NCT01987895 Org: User:
Start: 03/27/14 End: 03/24/17 Due: 03/24/18

Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT02260557 Org: User:
Start: 10/31/14 End: 06/30/15 Due: 06/30/16

Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma

Phase: N/A Priority: Normal
NCT ID: NCT00070590 Org: User:
Start: 07/31/03 End: 09/30/05 Due: 09/30/06

Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01437878 Org: User:
Start: 03/31/12 End: 11/30/12 Due: 11/30/13

The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02558231 Org: User:
Start: 05/01/16 End: 04/20/20 Due: 04/20/21

Miglustat in Niemann-Pick Type C Disease

Phase: N/A Priority: Normal
NCT ID: NCT00517153 Org: User:
Start: 01/31/02 End: 01/31/08 Due: 01/31/09

Pulmonary Artery Remodelling With Bosentan

Phase: N/A Priority: Normal
NCT ID: NCT00595049 Org: User:
Start: 05/31/06 End: 06/30/10 Due: 06/30/11

Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea

Phase: N/A Priority: Normal
NCT ID: NCT01983683 Org: User:
Start: 12/12/13 End: 05/02/17 Due: 05/02/18